1,060
Participants
Start Date
May 12, 2020
Primary Completion Date
January 7, 2025
Study Completion Date
January 17, 2026
Pembrolizumab
IV infusion
Placebo for pembrolizumab
IV infusion
Cisplatin
IV infusion
External Beam Radiotherapy (EBRT)
Given as a total radiotherapy dose of 80 Gy for volume-directed and 75 Gy for point-directed
Brachytherapy
Given as a total radiotherapy dose of 80 Gy for volume-directed and 75 Gy for point-directed
National Taiwan University Hospital ( Site 1095), Taipei
Mackay Memorial Hospital ( Site 1094), Taipei
Linkou Chang Gung Memorial Hospital ( Site 1097), Taoyuan District
Medizinische Universität Wien ( Site 0567), Vienna
Orszagos Onkologiai Intezet ( Site 0846), Budapest
Westmead Hospital ( Site 0973), Westmead
GZA Sint Augustinus ( Site 0356), Wilrijk
UZA University Hospital Antwerp ( Site 0351), Edegem
Peter MacCallum Cancer Centre ( Site 0971), Melbourne
UZ Leuven ( Site 0354), Leuven
Monash Health-Monash Medical Centre ( Site 0970), Clayton
Royal Brisbane and Women s Hospital ( Site 0972), Herston
Debreceni Egyetem Klinikai Kozpont ( Site 0845), Debrecen
Helse Bergen HF Haukeland Universitetssjukehus ( Site 0601), Bergen
St John of God Subiaco Hospital ( Site 0969), Subiaco
Medizinische Universitat Innsbruck ( Site 0566), Innsbruck
C.I.U. Hopital Ambroise Pare ( Site 0353), Mons
Medizinische Universitat Graz ( Site 0569), Graz
AZ St Lucas ( Site 0349), Ghent
OLV Ziekenhuis ( Site 0352), Aalst
Istituto di Candiolo - IRCCS ( Site 0546), Candiolo
A.O.U. Citta della Salute e della Scienza di Torino ( Site 0535), Torino
Ramathibodi Hospital, Mahidol University ( Site 1131), Rajthevee
National Cancer Center ( Site 1065), Goyang-si
Alexandra General Hospital ( Site 0477), Athens
Hospital de Alta Complejidad de La Libertad Virgen de La Puerta ( Site 0287), Trujillo
Charite Universitaetsmedizin Berlin ( Site 0442), Berlin
Instituto de Oncologia y Radioterapia Clinica Ricardo Palma ( Site 0290), Lima
Hospital Nacional Arzobispo Loayza ( Site 0292), Lima
Hospital Nacional Guillermo Almenara Irigoyen ( Site 0291), Lima
Clinica San Gabriel ( Site 0296), San Miguel
Allegheny Health Network West Penn Hospital-Gynecologic Oncology ( Site 0030), Pittsburgh
Hosp Clin Univ de Santiago ( Site 0629), Santiago de Compostela
IRCCS Ospedale San Raffaele ( Site 0539), Milan
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0542), Milan
Istituto Europeo di Oncologia ( Site 0536), Milan
Universitaetsklinikum Hamburg-Eppendorf ( Site 0445), Hamburg
UVA Health System ( Site 0005), Charlottesville
Complejo Hospitalario de Jaen ( Site 0632), Jaén
Virginia Commonwealth University ( Site 0024), Richmond
CHU Jean Minjoz ( Site 0411), Besançon
University of North Carolina at Chapel Hill ( Site 0025), Chapel Hill
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 0638), Pozuelo de Alarcón
Hollings Cancer Center ( Site 0007), Charleston
Institut Claudius Regaud ( Site 0417), Toulouse
AdventHealth Orlando-AdventHealth Medical Group Gynecological Oncology ( Site 0009), Orlando
I.U. Cerrahpasa Medical Faculty ( Site 0755), Istanbul
Srinagarind Hospital. Khon Kaen University ( Site 1132), Mueang
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 0541), Bologna
University of Kentucky Markey Cancer Center ( Site 0015), Lexington
Keimyung University Dongsan Medical Center ( Site 1066), Daegu
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus
Parkview Research Center at Parkview Regional Medical Center ( Site 0026), Fort Wayne
Karmanos Cancer Institute ( Site 0018), Detroit
Hospital Clinico Universitario Lozano Blesa ( Site 0630), Zaragoza
Maharaj Nakorn Chiang Mai Hospital ( Site 1133), Chiang Mai
Minnesota Oncology Hematology, PA ( Site 8007), Minneapolis
Sanford Gynecology Oncology ( Site 0003), Sioux Falls
Sanford Bismarck Medical Center ( Site 0046), Bismarck
Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 0876), Kharkiv
Universitätsmedizin Mannheim-Department of Obstetrics and Gynecology ( Site 0443), Mannheim
Centre Hospitalier Lyon Sud ( Site 0413), Pierre-Bénite
Women's Cancer Care ( Site 0039), Covington
Our Lady of the Lake Regional Medical Center. ( Site 0031), Baton Rouge
Ospedale Vito Fazzi ( Site 0547), Lecce
Texas Oncology-Fort Worth Cancer Center ( Site 8001), Fort Worth
Texas Oncology-The Woodlands ( Site 8003), The Woodlands
Texas Oncology-San Antonio Medical Center ( Site 8002), San Antonio
Texas Oncology-Austin Central ( Site 8006), Austin
Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 0882), Lviv
Universitaetsklinikum Freiburg ( Site 0454), Freiburg im Breisgau
Fondazione Giovanni Pascale Di Napoli ( Site 0544), Napoli
University of Colorado Health Sciences Center and Hospital ( Site 0028), Denver
Klinikum der Universitaet in Muenchen ( Site 0446), Munich
Klinikum Rechts der Isar. Technischen Universitaet Muenchen ( Site 0453), Munich
HonorHealth Research Institute - Biltmore ( Site 8009), Phoenix
University of New Mexico Comprehensive Cancer Center-Clinical Research Office ( Site 0019), Albuquerque
UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0027), Los Angeles
Songklanagarind Hospital ( Site 1130), Hat Yai
Hoag Memorial Hospital Presbyterian ( Site 0038), Newport Beach
UC Davis Comprehensive Cancer Center ( Site 0017), Sacramento
Legacy Good Samaritan Medical Center ( Site 0013), Portland
Willamette Valley Cancer Institute and Research Center ( Site 8000), Eugene
Peking Union Medical College Hospital ( Site 1001), Beijing
Instituto Nacional de Cancerologia E.S.E ( Site 0228), Bogotá
MSROI named after P.A. Hertsen branch of FSBI NMRC Radiology ( Site 0722), Moscow
Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 0734), Yaroslavl
Harbin Medical University Cancer Hospital ( Site 1013), Harbin
GBUZ SPb CRPCstmc(o) ( Site 0746), Saint Petersburg
National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 0725), Saint Petersburg
Shanghai Cancer Hospital ( Site 1000), Shanghai
Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 1039), Shanghai
Anhui Provincial Hospital ( Site 1029), Hefei
Anhui Provincial Cancer Hospital ( Site 1007), Hefei
Hunan Cancer Hospital ( Site 1015), Changsha
Zhejiang Provincial People's Hospital ( Site 1021), Hangzhou
Zhejiang Cancer Hospital ( Site 1004), Hangzhou
The First Affiliated Hospital of Xiamen University ( Site 1025), Xiamen
Chongqing Cancer Hospital ( Site 1030), Chongqing
Xiangya Hospital Central-South University ( Site 1009), Changsha
Chelyabinsk Regional Clinical Center Oncology and Nuclear Medicine ( Site 0741), Chelyabinsk
The First Affiliated Hospital.Sun Yat-sen University ( Site 1005), Guangzhou
Affiliated Cancer Hospital of Guangxi Medical University ( Site 1036), Nanning
Sichuan Cancer Hospital ( Site 1018), Chengdu
Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0729), Krasnoyarsk
Fundacion Valle del Lili ( Site 0230), Santiago de Cali
Centro Medico Imbanaco de Cali S.A ( Site 0227), Santiago de Cali
The First Affiliated Hospital of Xinjiang Medical University ( Site 1012), Ürümqi
National Cancer Center Hospital East ( Site 1159), Kashiwa
Rambam Medical Center ( Site 0815), Haifa
Centro Investigación del Cáncer James Lind ( Site 0194), Temuco
Chaim Sheba Medical Center ( Site 0814), Ramat Gan
Sourasky Medical Center ( Site 0819), Tel Aviv
Sociedad Oncovida S.A. ( Site 0196), Santiago
Iram Cancer Research ( Site 0198), Santiago
Hadassah Medical Center. Ein Kerem ( Site 0816), Jerusalem
Hospital de Clínicas de Ribeirão Preto ( Site 0171), Ribeirão Preto
Smilow Cancer Center at Yale-New Haven ( Site 0023), New Haven
Hospital das Clinicas da UFMG ( Site 0172), Belo Horizonte
Liga Norte Riograndense Contra o Cancer ( Site 0170), Natal
Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0166), São Paulo
Instituto Nacional Do Cancer II ( Site 0173), Rio de Janeiro
Princess Margaret Cancer Centre ( Site 0102), Toronto
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0101), Montreal
McGill University Health Centre ( Site 0105), Montreal
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Québec
Oncocentro ( Site 0195), Viña del Mar
Royal Devon and Exeter Foundation Trust Hospital ( Site 0699), Exeter
Fundacion Centro de Investigacion Clinica CIC ( Site 0231), Medellín
Fakultni Nemocnice Brno Bohunice ( Site 0912), Brno
Fakultni nemocnice Ostrava ( Site 0909), Ostrava
Fakultni nemocnice Kralovske Vinohrady ( Site 0913), Prague
Universitaetsklinikum Carl Gustav Carus der Technischen Univ ( Site 0452), Dresden
Universitaetsklinik Leipzig ( Site 0456), Leipzig
General Hospital of Patras. St Andrews ( Site 0473), Pátrai
Hospital Hygeia ( Site 0478), Athens
Euromedica General Clinic of Thessaloniki ( Site 0474), Thessaloniki
Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0321), Guatemala City
Oncologika S.A. ( Site 0323), Guatemala City
Oncomedica ( Site 0320), Guatemala City
Grupo Angeles SA ( Site 0319), Guatemala City
Medi-K Cayala ( Site 0318), Guatemala City
Centro Medico Integral De Cancerología (CEMIC) ( Site 0322), Quetzaltenango
Cork University Hospital ( Site 0504), Cork
St James Hospital ( Site 0505), Dublin
Istituto Nazionale Tumori Regina Elena ( Site 0540), Rome
Policlinico Universitario Gemelli ( Site 0538), Roma
Aichi Cancer Center Hospital ( Site 1155), Nagoya
National Hospital Organization Shikoku Cancer Center ( Site 1162), Matsuyama
Ehime University Hospital ( Site 1157), Tōon
Kurume University Hospital ( Site 1164), Kurume
Hokkaido University Hospital ( Site 1163), Sapporo
Iwate Medical University Hospital ( Site 1165), Shiwa-gun
University of the Ryukyus Hospital ( Site 1156), Nakagami-gun
Saitama Medical University International Medical Center ( Site 1168), Hidaka
Saitama Cancer Center ( Site 1169), Kitaadachi-gun
Kyorin University Hospital ( Site 1158), Mitaka
National Hospital Organization Kyushu Cancer Center ( Site 1167), Fukuoka
Kagoshima City Hospital ( Site 1166), Kagoshima
Osaka International Cancer Institute ( Site 1161), Osaka
National Cancer Center Hospital ( Site 1172), Tokyo
Japanese Foundation for Cancer Research-Gynecologic Oncology ( Site 1171), Tokyo
Keio University Hospital ( Site 1170), Tokyo
Oslo Universitetssykehus Radiumhospitalet ( Site 0600), Oslo
Centro Medico Monte Carmelo ( Site 0289), Arequipa
Hospital Nacional Daniel Alcides Carrion ( Site 0293), Callao
Asan Medical Center ( Site 1062), Seoul
Severance Hospital ( Site 1063), Seoul
Samsung Medical Center ( Site 1064), Seoul
Hospital Germans Trias i Pujol-Instituto Catalán de Oncología de Badalona ( Site 0637), Badalona
Hospital Universitari Vall d Hebron ( Site 0634), Barcelona
Karolinska Universitetssjukhuset ( Site 0784), Stockholm
Acibadem Adana Hastanesi ( Site 0756), Adana
Baskent Universitesi Ankara Hastanesi ( Site 0754), Ankara
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 0701), London
Royal Marsden Hospital (Sutton)-Gynaecology Unit ( Site 0696), London
GOG Foundation
NETWORK
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
Merck Sharp & Dohme LLC
INDUSTRY